Large Cap High Growth Potential

Results

17

2 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

17 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	VACN	CHF 634.40	5.1%	122.8%	CHF 18.9b	CHF 699.94	91.6	24.8%	1.1%	Capital Goods
	STMN	CHF 102.20	0.3%	-0.2%	CHF 16.7b	CHF 110.33	45.7	15.7%	1.0%	Healthcare
	BEAN	CHF 859.00	2.8%	-7.5%	CHF 10.6b	CHF 1,018.90	51.5	13.9%	1.2%	Capital Goods
	GALD	CHF 178.25	-1.3%	36.7%	CHF 41.6b	CHF 192.09	59.5	22.9%	0.2%	Pharmaceuticals & Biotech
	HBAN	CHF 216.80	0.4%	4.4%	CHF 21.4b	CHF 231.36	39.3	29.6%	3.6%	Insurance
	HOLN New	CHF 72.58	-3.8%	7.5%	CHF 40.2b	CHF 82.05	102.2	26.1%	2.3%	Materials
	SDZ New	CHF 69.18	2.7%	36.9%	CHF 29.5b	CHF 71.17	57.2	24.2%	1.1%	Pharmaceuticals & Biotech
	NOVN	CHF 125.18	-1.3%	34.5%	CHF 236.6b	CHF 124.70	23.0	11.0%	2.9%	Pharmaceuticals & Biotech
	SOON	CHF 233.80	7.1%	5.5%	CHF 13.8b	CHF 223.72	25.9	10.4%	2.0%	Healthcare
	UHR	CHF 189.05	4.9%	33.3%	CHF 9.8b	CHF 169.54	1092.2	40.8%	2.4%	Consumer Durables
	NESN	CHF 81.12	-1.5%	12.6%	CHF 209.3b	CHF 88.87	28.0	12.3%	3.8%	Food, Beverage & Tobacco
	LONN	CHF 566.60	-0.6%	3.1%	CHF 39.2b	CHF 680.70	36.6	17.3%	0.9%	Pharmaceuticals & Biotech
	CFR	CHF 195.45	2.4%	48.2%	CHF 115.0b	CHF 210.42	35.5	15.5%	1.7%	Consumer Durables
	SGSN	CHF 96.80	0.4%	15.3%	CHF 19.3b	CHF 101.63	28.9	10.1%	3.3%	Commercial Services
	PGHN	CHF 722.40	7.6%	-36.0%	CHF 18.6b	CHF 825.00	14.8	6.4%	6.4%	Diversified Financials
	ALC	CHF 56.42	0.5%	-17.9%	CHF 27.7b	CHF 76.39	41.5	18.2%	0.5%	Healthcare
	ABBN	CHF 81.76	2.8%	52.0%	CHF 148.4b	CHF 80.79	36.9	7.6%	1.1%	Capital Goods

Page 1 of 1